Growth hormone deficiency in a Nigerian child with Turner’s syndrome: a case report and review of growth assessment in children.
DOI:
https://doi.org/10.60787/tnhj.v16i2.202Keywords:
Turner syndrome, growth hormone deficiency, Nigeria, growth hormone treatmentAbstract
Turner syndrome is the most common chromosomal abnormality affecting women with a prevalence of 1 in 2000 live births. Genetics show that most of the patients have monosomy 45 XO and the commonest phenotype is short stature. Growth hormone deficiency is uncommon but concensus statements have endorsed GH treatment for short girls with Turner syndrome.
Case report: A 15 year old Turner syndrome patient who had delayed evaluation for short status was noticed to be short for age, with a height of 125 cm (-5SDS). Growth hormone stimulation test revealed growth hormone deficiency and she was commenced on growth hormone therapy.
Conclusion: Simple and regular measurement of children’s height with chart plotting is necessary to pick up children who have short status. Growth hormone treatment early in the course of management of a child with Turner syndrome may help achieve normal final height.
Downloads
References
Stockholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab. 2006;91: 3897–3902.
Ranke MB, Stubbe P, Majewski F, Bierich JR. Spontaneous growth in Turner’s syndrome. Acta Paediatr Scand Suppl. 1988; 343:22–30.
Cavallo L, Gurrado R. Endogenous growth hormone secretion does not correlate with growth in patients with Turner’s syndrome. Italian Study Group for Turner Syndrome. J Pediatr Endocrinol Metab. 1999; 12:623–627.
Blum WF, Cao D, Hesse V, et al. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome. Horm Res. 2009;71(3): 167–172.
Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab. 2000; 85:3990–3993.
Ito Y, Fujieda K, Tanaka T, et al. Low-dose growth hormone treatment (0.175 mg/kg/week) for short stature in patients with Turner Syndrome: data from KIGS Japan. Endocr J. 2006;53:699–703.
Van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, et al. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab. 2003;88: 1119–25.
Reh S C, Geffner M E. Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review. Clinical Pharmacology: Advances and Applications 2010:2;111–122
Cunniff C, Jones KL, Benirschke K. Ovarian dysgenesis in individuals with chromosomal abnormalities. Human Genetics. 1991;86:552–6.
Bryman I, Sylvén L, Berntorp K, Innala E, Bergström I, Hanson C, et al. Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertil Steril. 2011;95:2507–2510.
Habrecht MF, Menon V, Warsofsky IS, et al. Functional neuroanatomy of visuo-spatial working memory in Turner syndrome. Hum Brain Mapp 2001;14:96-107.
Elliot TK, Watkins JM, Messa C, et al. Positron emission tomography and neuropsychological correlations in children with Turner’s syndrome. Dev Neuropsychol 1996;12:365-86.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 The Nigerian Health Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
